TY - JOUR
T1 - Rapid ultrasensitive detection platform for antimicrobial susceptibility testing
AU - Cansizoglu, Mehmet F.
AU - Tamer, Yusuf Talha
AU - Farid, Michael
AU - Koh, Andrew Y.
AU - Toprak, Erdal
N1 - Funding Information:
This work was supported by the UTSW Endowed Scholars Program (ET), Human Frontiers Science Program Research Grant RGP0042/2013 (ET), National Institutes of Health grant R01GM125748 (ET), DOD PR172118 (ET), and National Institutes of Health grant R01AI123163 (AYK), as well as the Roberta I. and Norman L. Pollock Fund (AYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr. Laura Filkins from the Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, for providing the clinical isolates and reagents used in this study as well as technical expertise on the clinical antibiotic susceptibility tests performed. We also thank Marinelle Rodrigues and Laura Coughlin for technical help and advice.
Publisher Copyright:
© 2019 Cansizoglu et al.
PY - 2019
Y1 - 2019
N2 - Rapid detection and phenotyping of pathogenic microbes is critical for administration of effective antibiotic therapies and for impeding the spread of antibiotic resistance. Here, we present a novel platform, rapid ultrasensitive detector (RUSD), that utilizes the high reflectance coefficient at high incidence angles when light travels from low- to high-refractive-index media. RUSD leverages a principle that does not require complex manufacturing, labeling, or processing steps. Utilizing RUSD, we can detect extremely low cell densities (optical density [OD] ≥ 5 × 10−7) that correspond to approximately 20 bacterial cells or a single fungal cell in the detection volume, which is nearly 4 orders of magnitude more sensitive than standard OD methods. RUSD can measure minimum inhibitory concentrations (MICs) of commonly used antibiotics against gram-negative and gram-positive bacteria, including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli, within 2 to 4 h. Here, we demonstrate that antibiotic susceptibility tests for several pathogens can rapidly be performed with RUSD using both small inoculum sizes (500 cells/mL) and larger inoculum sizes (5 × 105 cells/mL) used in standard antibiotic susceptibility tests. We anticipate that the RUSD system will be particularly useful for the cases in which antibiotic susceptibility tests have to be done with a limited number of bacterial cells that are available. Its compatibility with standard antibiotic susceptibility tests, simplicity, and low cost can make RUSD a viable and rapidly deployed diagnostic tool.
AB - Rapid detection and phenotyping of pathogenic microbes is critical for administration of effective antibiotic therapies and for impeding the spread of antibiotic resistance. Here, we present a novel platform, rapid ultrasensitive detector (RUSD), that utilizes the high reflectance coefficient at high incidence angles when light travels from low- to high-refractive-index media. RUSD leverages a principle that does not require complex manufacturing, labeling, or processing steps. Utilizing RUSD, we can detect extremely low cell densities (optical density [OD] ≥ 5 × 10−7) that correspond to approximately 20 bacterial cells or a single fungal cell in the detection volume, which is nearly 4 orders of magnitude more sensitive than standard OD methods. RUSD can measure minimum inhibitory concentrations (MICs) of commonly used antibiotics against gram-negative and gram-positive bacteria, including Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli, within 2 to 4 h. Here, we demonstrate that antibiotic susceptibility tests for several pathogens can rapidly be performed with RUSD using both small inoculum sizes (500 cells/mL) and larger inoculum sizes (5 × 105 cells/mL) used in standard antibiotic susceptibility tests. We anticipate that the RUSD system will be particularly useful for the cases in which antibiotic susceptibility tests have to be done with a limited number of bacterial cells that are available. Its compatibility with standard antibiotic susceptibility tests, simplicity, and low cost can make RUSD a viable and rapidly deployed diagnostic tool.
UR - http://www.scopus.com/inward/record.url?scp=85067910301&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067910301&partnerID=8YFLogxK
U2 - 10.1371/journal.pbio.3000291
DO - 10.1371/journal.pbio.3000291
M3 - Article
C2 - 31145726
AN - SCOPUS:85067910301
SN - 1544-9173
VL - 17
JO - PLoS Biology
JF - PLoS Biology
IS - 5
ER -